基本信息
-
HIV-1 TAT PROTEIN (47-57)
-
191936-91-1
-
TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG: YGRKKRRQRRR
-
C64H118N32O14
-
1559.83
-
L-Arginine,L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-
-
-
1.54±0.1 g/cm3(Predicted)
-
10: PN:JP2003009883 SEQID: 7 unclaimed; 10: PN: US20030008961 SEQID: 10 unclaimedsequence; 10: PN: US20090047703 SEQID: 10 unclaimed protein; 10: PN:US20100008891 SEQID: 10 unclaimed protein; 10: PN: WO0168854 SEQID: 8 unclaimedprotein; 10: PN: WO0170977 SEQID: 9 unclaimed protein; 10: PN: WO2009114614SEQID: 10 unclaimed protein; 10: PN: WO2009149562 SEQID: 9 claimed sequence;110: PN: JP2001157588 SEQID: 3 unclaimed protein; 115: PN: WO2004089396 PAGE:14 unclaimed sequence; 11: PN: US20020127647 SEQID: 13 unclaimed sequence; 11:PN: WO03106626 SEQID: 24 unclaimed sequence; 11: PN: WO2004096826 PAGE: 17claimed sequence; 11: PN: WO2009039188 PAGE: 19 unclaimed sequence; 126: PN:WO2009029678 SEQID: 125 unclaimed sequence; 127: PN: WO03068930 SEQID: 127unclaimed sequence; 12: PN: US20030190364 SEQID: 12 claimed sequence; 12: PN:US20070154437 SEQID: 11 claimed sequence; 12: PN: US20070191591 SEQID: 12claimed sequence; 12: PN: US7329729 SEQID: 12 unclaimed sequence; 12: PN:WO2005072159 SEQID:
-
-
-
-
详细信息
杭州专肽生物(www.allpeptide.com)一直致力于、专注于修饰多肽的合成及研发,目前已经在很多方面取得了突破,并获得定制多肽行业的认可。 各类修饰让多肽的结构丰富起来,可以在多肽的N端、C端、活性侧链基团(羧基、氨基、羟基、酚羟基、巯基等)进行改造或形成各类环肽。同时多肽修饰让多肽的运用更加广泛起来,几乎所有的生物研究领域都有涉及到多肽,包括比较热门的肿瘤领域、生物材料领域,核磁共振领域等。
各类糖肽
各类荧光标记肽(Fam、FITC、TAMRRA、CY等)
含有DOTA、NOTA、DTPA等放射性螯合物前体多肽
众多羧基化合物和氨基化合物修饰的肽段
引入叠氮、炔基、烯基结构的肽段及点击化学运用
小分子、大分子PEG修饰
环肽(如酰胺、二硫键、硫酯、硫醚键、脲基成环)
引入叠氮、炔基、烯基结构的肽段及点击化学运用
同位素标记肽
环二肽
KLH和BSA蛋白载体多肽
R8S17订书肽
Dansyl和EDANS双标记肽
磷酸化肽磺酸化肽
甲基化肽
MAPs多聚抗原肽
醛肽
CMK、AMC、pNA